UKITP Registry
Trial overview
UK Adult Idiopathic Thrombocytopenic Purpura Registry
Inclusion criteria
Adult patients presenting at haematology clinics at The Royal London Hospital or collaborating centres with a low platelet count (< 150 × 109/L) and no evidence of known thrombocytopenic-inducing disease or treatments following a standard ITP workup will be invited to take part in the study.
Contact details
Other trials currently active for Thrombocytopenia
A multi-centre, single intravenous dose, exploratory dose-finding, open label trial on the safety and efficacy of Sym001 in the treatment of Immune Thrombocytopenic Purpura (ITP) in RhD positive, nonsplenectomized adult subjects.
A Phase 2, Interventional, Single Arm Study Describing Platelet Responses and ITP Remission Rates in Adult Subjects with Immune Thrombocytopenia Purpura Receving Romiplostim.
The secondary objectives are:
- To describe the incidence of ITP remission.
- To describe the incidence of splenectomy.
- To describe the incidence of adverse events.